Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 12/20 | 0.45 |
| ▸ | TYMS | P04818 | 2/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.37 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7313381 | 0.98 | TGM2 (0.46) | TGM2TYMSHDAC6HDAC3HDAC1 | |
| SCHEMBL7312881 | 0.85 | TGM2 (0.49) | TGM2TYMSHDAC6HDAC3HDAC1 | |
| SCHEMBL7373560 | 0.84 | ELANE (0.37) | TGM2ELANE | |
| SCHEMBL7373562 | 0.84 | ELANE (0.37) | TGM2ELANE | |
| SCHEMBL7311564 | 0.83 | FOLH1 (0.43) | ELANE | |
| SCHEMBL7311558 | 0.83 | FOLH1 (0.43) | ELANE | |
| Hydrochloric Acid SCHEMBL7347401 | 0.79 | TGM2 (0.42) | TGM2HDAC6HDAC4HDAC10HDAC5 | |
| SCHEMBL7371476 | 0.78 | FOLH1 (0.40) | TGM2ELANE | |
| SCHEMBL7371479 | 0.78 | FOLH1 (0.40) | TGM2ELANE | |
| SCHEMBL7317256 | 0.77 | TGM2 (0.43) | TGM2HDAC6HDAC4HDAC10HDAC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5110812-A | Treatment of pancreatitis; anticoagulants | BRISTOL-MYERS SQUIBB CO. (US) | 1992-05-05 | — | — | US | claimed |
| US-5326863-A | Antithrombin and antitrypsin activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-07-05 | — | — | US | disclosed |